The future of breast cancer systemic therapy: the next 10 years.
about
Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?Perspective on the dynamics of cancer.MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer.Multilayer photodynamic therapy for highly effective and safe cancer treatment.Imaging Tumor Proliferation in Breast Cancer: Current Update on Predictive Imaging Biomarkers
P2860
The future of breast cancer systemic therapy: the next 10 years.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The future of breast cancer systemic therapy: the next 10 years.
@en
type
label
The future of breast cancer systemic therapy: the next 10 years.
@en
prefLabel
The future of breast cancer systemic therapy: the next 10 years.
@en
P2860
P1476
The future of breast cancer systemic therapy: the next 10 years.
@en
P2093
George W Sledge
Melinda L Telli
P2860
P2888
P304
P356
10.1007/S00109-014-1238-Y
P577
2015-01-09T00:00:00Z
P6179
1041547467